Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Toluwalase Awoyemi, DPhil student in Nuffield Department of Women's & Reproductive Health, is recognised with an Africa 35.35 Award - a celebration of the top 35 leading young changemakers under 35 in Africa in 2020.

Toluwalase Awoyemi talking to a group of students in Nigeria

35 young changemakers from Africa and the diaspora hailing from 24 countries made it to the list of the Africa 35.35 Awards celebrating African youth and afro-diaspora excellence.

The Africa 35.35 Awards have announced the 35 under 35 most inspiring young personalities in Africa. It is a prestigious list of 35 young personalities aged 18 to 35 who stand out in Africa and around the world.

Selected from more than 500 applicants, these young people living in Africa and in the Diaspora are credited with exceptional achievements in their communities.

We are extremely proud to say that one of the winners is Dr Toluwalase Awoyemi, a Rhodes scholar, DPhil student at the Nuffield Department of Women's Reproductive Health, University of Oxford and co-founder of The Ganglion Initiative. This social enterprise aims to improve college admission services and career counseling really early, engaging students in public high schools across Nigeria. It organizes free webinars for admission to foreign scholarships with a fairly remarkable total audience of 2,221 people in the first two editions.

The full story is available on the Nuffield Department of Women's & Reproductive Health website

Similar stories

Professor Dame Sarah Gilbert delivers 44th Dimbleby Lecture

Professor Dame Sarah Gilbert, Saïd Professorship of Vaccinology, Jenner Institute & Nuffield Department of Clinical Medicine, delivered the 44th Richard Dimbleby Lecture, named after the late broadcaster, Richard Dimbleby.

Com-COV2 study supports flexible second dose options following Pfizer or Oxford/AstraZeneca jabs

Following up first doses of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines with second doses of the Moderna or Novavax jabs will generate robust immune responses against COVID-19, according to researchers running the University of Oxford-led Com-COV study.

Meta must do better - data from social media giant essential to mental health research

People are rightly sceptical about scientific discoveries made in secret or without scrutiny. And anyone claiming to have found a new planet with a toy telescope, would not be taken seriously. Recent leaks of internal Facebook research on the mental health of children and young people have caused a great stir on both sides of the Atlantic.

New Oxford-GSK Institute to harness advanced technology and unravel mechanisms of disease

GlaxoSmithKline plc and the University of Oxford today announced a major five-year collaboration to establish the Oxford-GSK Institute of Molecular and Computational Medicine.

Oxford researchers honoured by British Society for Immunology

Four researchers from the University of Oxford have been recognised for their outstanding contributions to immunology with Honorary Lifetime Membership of the British Society for Immunology, with the awards being announced at the recent British Society for Immunology Congress held in Edinburgh.

Medical Sciences researchers scoop 2021 Times Higher Education Awards

Coronavirus researchers from across Medical Sciences have been honoured at the 2021 Times Higher Education (THE) Awards.